ArticleIntensive care medicine2025
Correction: Heterogenous treatment effect of neuromuscular blocking agents for moderate-to-severe ARDS: a post hoc Markov model re-analysis of the ACURASYS trial.
Michael Brunini et al.PubMed ↗Publisher ↗
No numbers read from the abstract.